Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS Adjunct Therapy on Pulmonary Vascular Endothelial Function in COPD
NCT05607719Phase 2Completed
- Sponsor
- University of Miami
- Start
- Apr 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Miami. Primary endpoint: Albuterol induced percent change in pulmonary vascular resistance at 15 minutes. Started Apr 2023; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05607719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05607719.